Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMPIN vs RIFAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMPIN vs RIFAMYCIN: Safety Overview

Metric RIFAMPIN RIFAMYCIN
Total FAERS Reports 13,347 106
Deaths Reported 1,439 26
Death Rate 10.8% 24.5%
Hospitalizations 5,764 35
Average Patient Age 51.7 yrs 56.1 yrs
% Female Patients 47.8% 54.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Nov 16, 2018
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Discontinued